5-alpha Reductase Inhibitors [moft]    
Cardiovascular Diseases [dsyn]    
Patients [podg]    
Benign Prostate Hyperplasia [neop]    
Five [qnco]    
YEAR [tmco]    
Study, Followup [resa]    
Population Based Study [resa]    
investigated [ftcn]    
Cardiovascular Diseases [dsyn]    
5-alpha Reductase Inhibitor [phsu]    
therapy [ftcn]    
Benign Prostate Hyperplasia [neop]    
National Health Insurance [hlca]    
Research [resa]    
data base [inpr]    
TAIWAN [geoa]    
Methods [inpr]    
ADULT [aggp]    
Patients [podg]    
newly [idcn]    
Diagnosed [fndg]    
Benign Prostate Hyperplasia [neop]    
5-alpha Reductase Inhibitors [moft]    
Study [mnob]    
Subject [grup]    
5-alpha Reductase Inhibitors [moft]    
Comparison [acty]    
monitor [hlca]    
YEARS [tmco]    
Cardiovascular Diseases [dsyn]    
Identified [qlco]    
Cardiovascular Diseases [dsyn]    
Study [mnob]    
Comparison [acty]    
cohorts [popg]    
Risk Factors [qnco]    
Patients [podg]    
RECEIVED [qlco]    
5-alpha Reductase Inhibitor [phsu]    
therapy [ftcn]    
LOWER [spco]    
Cumulative [qlco]    
Cardiovascular Diseases [dsyn]    
Receive [qlco]    
5-alpha Reductase Inhibitor [phsu]    
therapy [ftcn]    
YEAR [tmco]    
Subgroup Analysis [resa]    
YEAR [tmco]    
Cardiovascular event [fndg]    
Hazard Ratio [qnco]    
LOWER [spco]    
Patients [podg]    
Old [tmco]    
YEARS [tmco]    
Cumulative Dose [cnce]    
Defined [inpr]    
Daily [tmco]    
5-alpha Reductase Inhibitor [phsu]    
Hazard Ratio [qnco]    
0.018" [qnco]    
Patients [podg]    
>90 [qnco]    
Cumulative Dose [cnce]    
Defined [inpr]    
Daily [tmco]    
5-alpha Reductase Inhibitor [phsu]    
Hazard Ratio [qnco]    
Hazard Ratio [qnco]    
Conclusions [idcn]    
5-alpha Reductase Inhibitor [phsu]    
therapy [ftcn]    
cardiovascular events [fndg]    
Benign Prostate Hyperplasia [neop]    
Patients [podg]    
YEARS [tmco]    
Mechanisms [ftcn]    
Research [resa]    
Needed [qlco]    
